Overexpressed Rad51 (Harris et al., 2018), BRCA1 (Zhu et al., 2018), and MDC1 (Singh et al., 2020) contribute to genomic integrity and chemoresistance in cancer. The gene discussed is RAD51; the disease is cancer.